The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Penem APIs and Intermediates Market Research Report 2025
Synopsis
Penem APIs and intermediates are chemical raw materials and drug intermediates used to synthesize penem antibiotics. Penem Antibiotics (Carbapenems) are a class of very effective antibiotic agents most commonly used for treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta-lactam antibiotics drug class, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.
The global Penem APIs and Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Penem APIs and Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Penem APIs and Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Penem APIs and Intermediates include Shenzhen Haibin Pharmaceutical, Hainan Haiyao, Qilu Antibiotics Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Hisoar Pharmaceutical, Sun Pharmaceutical, Savior Lifetec, ACS Dobfar, Kopran, High Tech Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Penem APIs and Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penem APIs and Intermediates.
The Penem APIs and Intermediates market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Penem APIs and Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Penem APIs and Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Haibin Pharmaceutical
Hainan Haiyao
Qilu Antibiotics Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Hisoar Pharmaceutical
Sun Pharmaceutical
Savior Lifetec
ACS Dobfar
Kopran
High Tech Pharm
Zhuhai United Laboratories
Cspc Holdings
Zhejiang Jiuzhou Pharmaceutical
Jiangxi Fushine Pharmaceutical
Sichuan Xindi Pharmaceutical
Jeil Pharma
Segment by Type
APIs
Intermediates
Segment by Application
Meropenem
Imipenem
Biapenem
Ertapenem
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Penem APIs and Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Penem APIs and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Penem APIs and intermediates are chemical raw materials and drug intermediates used to synthesize penem antibiotics. Penem Antibiotics (Carbapenems) are a class of very effective antibiotic agents most commonly used for treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta-lactam antibiotics drug class, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.
The global Penem APIs and Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Penem APIs and Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Penem APIs and Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Penem APIs and Intermediates include Shenzhen Haibin Pharmaceutical, Hainan Haiyao, Qilu Antibiotics Pharmaceutical, Zhejiang Hisun Pharmaceutical, Zhejiang Hisoar Pharmaceutical, Sun Pharmaceutical, Savior Lifetec, ACS Dobfar, Kopran, High Tech Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Penem APIs and Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penem APIs and Intermediates.
The Penem APIs and Intermediates market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Penem APIs and Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Penem APIs and Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Haibin Pharmaceutical
Hainan Haiyao
Qilu Antibiotics Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Hisoar Pharmaceutical
Sun Pharmaceutical
Savior Lifetec
ACS Dobfar
Kopran
High Tech Pharm
Zhuhai United Laboratories
Cspc Holdings
Zhejiang Jiuzhou Pharmaceutical
Jiangxi Fushine Pharmaceutical
Sichuan Xindi Pharmaceutical
Jeil Pharma
Segment by Type
APIs
Intermediates
Segment by Application
Meropenem
Imipenem
Biapenem
Ertapenem
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Penem APIs and Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Penem APIs and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Penem APIs and Intermediates Market Overview
1.1 Product Definition
1.2 Penem APIs and Intermediates by Type
1.2.1 Global Penem APIs and Intermediates Market Value Comparison by Type (2024-2030)
1.2.2 APIs
1.2.3 Intermediates
1.3 Penem APIs and Intermediates by Application
1.3.1 Global Penem APIs and Intermediates Market Value by Application (2024-2030)
1.3.2 Meropenem
1.3.3 Imipenem
1.3.4 Biapenem
1.3.5 Ertapenem
1.3.6 Others
1.4 Global Penem APIs and Intermediates Market Size Estimates and Forecasts
1.4.1 Global Penem APIs and Intermediates Revenue 2019-2030
1.4.2 Global Penem APIs and Intermediates Sales 2019-2030
1.4.3 Global Penem APIs and Intermediates Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Penem APIs and Intermediates Market Competition by Manufacturers
2.1 Global Penem APIs and Intermediates Sales Market Share by Manufacturers (2019-2024)
2.2 Global Penem APIs and Intermediates Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Penem APIs and Intermediates Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Penem APIs and Intermediates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Penem APIs and Intermediates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Penem APIs and Intermediates, Product Type & Application
2.7 Global Key Manufacturers of Penem APIs and Intermediates, Date of Enter into This Industry
2.8 Global Penem APIs and Intermediates Market Competitive Situation and Trends
2.8.1 Global Penem APIs and Intermediates Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Penem APIs and Intermediates Players Market Share by Revenue
2.8.3 Global Penem APIs and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Penem APIs and Intermediates Market Scenario by Region
3.1 Global Penem APIs and Intermediates Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Penem APIs and Intermediates Sales by Region: 2019-2030
3.2.1 Global Penem APIs and Intermediates Sales by Region: 2019-2024
3.2.2 Global Penem APIs and Intermediates Sales by Region: 2025-2030
3.3 Global Penem APIs and Intermediates Revenue by Region: 2019-2030
3.3.1 Global Penem APIs and Intermediates Revenue by Region: 2019-2024
3.3.2 Global Penem APIs and Intermediates Revenue by Region: 2025-2030
3.4 North America Penem APIs and Intermediates Market Facts & Figures by Country
3.4.1 North America Penem APIs and Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Penem APIs and Intermediates Sales by Country (2019-2030)
3.4.3 North America Penem APIs and Intermediates Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Penem APIs and Intermediates Market Facts & Figures by Country
3.5.1 Europe Penem APIs and Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Penem APIs and Intermediates Sales by Country (2019-2030)
3.5.3 Europe Penem APIs and Intermediates Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Penem APIs and Intermediates Market Facts & Figures by Region
3.6.1 Asia Pacific Penem APIs and Intermediates Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Penem APIs and Intermediates Sales by Region (2019-2030)
3.6.3 Asia Pacific Penem APIs and Intermediates Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Penem APIs and Intermediates Market Facts & Figures by Country
3.7.1 Latin America Penem APIs and Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Penem APIs and Intermediates Sales by Country (2019-2030)
3.7.3 Latin America Penem APIs and Intermediates Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Penem APIs and Intermediates Market Facts & Figures by Country
3.8.1 Middle East and Africa Penem APIs and Intermediates Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Penem APIs and Intermediates Sales by Country (2019-2030)
3.8.3 Middle East and Africa Penem APIs and Intermediates Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Penem APIs and Intermediates Sales by Type (2019-2030)
4.1.1 Global Penem APIs and Intermediates Sales by Type (2019-2024)
4.1.2 Global Penem APIs and Intermediates Sales by Type (2025-2030)
4.1.3 Global Penem APIs and Intermediates Sales Market Share by Type (2019-2030)
4.2 Global Penem APIs and Intermediates Revenue by Type (2019-2030)
4.2.1 Global Penem APIs and Intermediates Revenue by Type (2019-2024)
4.2.2 Global Penem APIs and Intermediates Revenue by Type (2025-2030)
4.2.3 Global Penem APIs and Intermediates Revenue Market Share by Type (2019-2030)
4.3 Global Penem APIs and Intermediates Price by Type (2019-2030)
5 Segment by Application
5.1 Global Penem APIs and Intermediates Sales by Application (2019-2030)
5.1.1 Global Penem APIs and Intermediates Sales by Application (2019-2024)
5.1.2 Global Penem APIs and Intermediates Sales by Application (2025-2030)
5.1.3 Global Penem APIs and Intermediates Sales Market Share by Application (2019-2030)
5.2 Global Penem APIs and Intermediates Revenue by Application (2019-2030)
5.2.1 Global Penem APIs and Intermediates Revenue by Application (2019-2024)
5.2.2 Global Penem APIs and Intermediates Revenue by Application (2025-2030)
5.2.3 Global Penem APIs and Intermediates Revenue Market Share by Application (2019-2030)
5.3 Global Penem APIs and Intermediates Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shenzhen Haibin Pharmaceutical
6.1.1 Shenzhen Haibin Pharmaceutical Company Information
6.1.2 Shenzhen Haibin Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.1.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.2 Hainan Haiyao
6.2.1 Hainan Haiyao Company Information
6.2.2 Hainan Haiyao Description and Business Overview
6.2.3 Hainan Haiyao Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hainan Haiyao Penem APIs and Intermediates Product Portfolio
6.2.5 Hainan Haiyao Recent Developments/Updates
6.3 Qilu Antibiotics Pharmaceutical
6.3.1 Qilu Antibiotics Pharmaceutical Company Information
6.3.2 Qilu Antibiotics Pharmaceutical Description and Business Overview
6.3.3 Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.3.5 Qilu Antibiotics Pharmaceutical Recent Developments/Updates
6.4 Zhejiang Hisun Pharmaceutical
6.4.1 Zhejiang Hisun Pharmaceutical Company Information
6.4.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.4.3 Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.4.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.5 Zhejiang Hisoar Pharmaceutical
6.5.1 Zhejiang Hisoar Pharmaceutical Company Information
6.5.2 Zhejiang Hisoar Pharmaceutical Description and Business Overview
6.5.3 Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.5.5 Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Company Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Savior Lifetec
6.7.1 Savior Lifetec Company Information
6.7.2 Savior Lifetec Description and Business Overview
6.7.3 Savior Lifetec Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Savior Lifetec Penem APIs and Intermediates Product Portfolio
6.7.5 Savior Lifetec Recent Developments/Updates
6.8 ACS Dobfar
6.8.1 ACS Dobfar Company Information
6.8.2 ACS Dobfar Description and Business Overview
6.8.3 ACS Dobfar Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ACS Dobfar Penem APIs and Intermediates Product Portfolio
6.8.5 ACS Dobfar Recent Developments/Updates
6.9 Kopran
6.9.1 Kopran Company Information
6.9.2 Kopran Description and Business Overview
6.9.3 Kopran Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kopran Penem APIs and Intermediates Product Portfolio
6.9.5 Kopran Recent Developments/Updates
6.10 High Tech Pharm
6.10.1 High Tech Pharm Company Information
6.10.2 High Tech Pharm Description and Business Overview
6.10.3 High Tech Pharm Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.10.4 High Tech Pharm Penem APIs and Intermediates Product Portfolio
6.10.5 High Tech Pharm Recent Developments/Updates
6.11 Zhuhai United Laboratories
6.11.1 Zhuhai United Laboratories Company Information
6.11.2 Zhuhai United Laboratories Description and Business Overview
6.11.3 Zhuhai United Laboratories Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhuhai United Laboratories Penem APIs and Intermediates Product Portfolio
6.11.5 Zhuhai United Laboratories Recent Developments/Updates
6.12 Cspc Holdings
6.12.1 Cspc Holdings Company Information
6.12.2 Cspc Holdings Description and Business Overview
6.12.3 Cspc Holdings Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cspc Holdings Penem APIs and Intermediates Product Portfolio
6.12.5 Cspc Holdings Recent Developments/Updates
6.13 Zhejiang Jiuzhou Pharmaceutical
6.13.1 Zhejiang Jiuzhou Pharmaceutical Company Information
6.13.2 Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
6.13.3 Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.13.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
6.14 Jiangxi Fushine Pharmaceutical
6.14.1 Jiangxi Fushine Pharmaceutical Company Information
6.14.2 Jiangxi Fushine Pharmaceutical Description and Business Overview
6.14.3 Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.14.5 Jiangxi Fushine Pharmaceutical Recent Developments/Updates
6.15 Sichuan Xindi Pharmaceutical
6.15.1 Sichuan Xindi Pharmaceutical Company Information
6.15.2 Sichuan Xindi Pharmaceutical Description and Business Overview
6.15.3 Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Product Portfolio
6.15.5 Sichuan Xindi Pharmaceutical Recent Developments/Updates
6.16 Jeil Pharma
6.16.1 Jeil Pharma Company Information
6.16.2 Jeil Pharma Description and Business Overview
6.16.3 Jeil Pharma Penem APIs and Intermediates Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jeil Pharma Penem APIs and Intermediates Product Portfolio
6.16.5 Jeil Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Penem APIs and Intermediates Industry Chain Analysis
7.2 Penem APIs and Intermediates Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Penem APIs and Intermediates Production Mode & Process
7.4 Penem APIs and Intermediates Sales and Marketing
7.4.1 Penem APIs and Intermediates Sales Channels
7.4.2 Penem APIs and Intermediates Distributors
7.5 Penem APIs and Intermediates Customers
8 Penem APIs and Intermediates Market Dynamics
8.1 Penem APIs and Intermediates Industry Trends
8.2 Penem APIs and Intermediates Market Drivers
8.3 Penem APIs and Intermediates Market Challenges
8.4 Penem APIs and Intermediates Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Penem APIs and Intermediates Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Penem APIs and Intermediates Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Penem APIs and Intermediates Market Competitive Situation by Manufacturers in 2023
Table 4. Global Penem APIs and Intermediates Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Penem APIs and Intermediates Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Penem APIs and Intermediates Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Penem APIs and Intermediates Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Penem APIs and Intermediates Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Penem APIs and Intermediates, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Penem APIs and Intermediates, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Penem APIs and Intermediates, Product Type & Application
Table 12. Global Key Manufacturers of Penem APIs and Intermediates, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Penem APIs and Intermediates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Penem APIs and Intermediates as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Penem APIs and Intermediates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Penem APIs and Intermediates Sales by Region (2019-2024) & (Tons)
Table 18. Global Penem APIs and Intermediates Sales Market Share by Region (2019-2024)
Table 19. Global Penem APIs and Intermediates Sales by Region (2025-2030) & (Tons)
Table 20. Global Penem APIs and Intermediates Sales Market Share by Region (2025-2030)
Table 21. Global Penem APIs and Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Penem APIs and Intermediates Revenue Market Share by Region (2019-2024)
Table 23. Global Penem APIs and Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Penem APIs and Intermediates Revenue Market Share by Region (2025-2030)
Table 25. North America Penem APIs and Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Penem APIs and Intermediates Sales by Country (2019-2024) & (Tons)
Table 27. North America Penem APIs and Intermediates Sales by Country (2025-2030) & (Tons)
Table 28. North America Penem APIs and Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Penem APIs and Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Penem APIs and Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Penem APIs and Intermediates Sales by Country (2019-2024) & (Tons)
Table 32. Europe Penem APIs and Intermediates Sales by Country (2025-2030) & (Tons)
Table 33. Europe Penem APIs and Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Penem APIs and Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Penem APIs and Intermediates Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Penem APIs and Intermediates Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Penem APIs and Intermediates Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Penem APIs and Intermediates Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Penem APIs and Intermediates Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Penem APIs and Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Penem APIs and Intermediates Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Penem APIs and Intermediates Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Penem APIs and Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Penem APIs and Intermediates Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Penem APIs and Intermediates Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Penem APIs and Intermediates Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Penem APIs and Intermediates Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Penem APIs and Intermediates Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Penem APIs and Intermediates Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Penem APIs and Intermediates Sales (Tons) by Type (2019-2024)
Table 51. Global Penem APIs and Intermediates Sales (Tons) by Type (2025-2030)
Table 52. Global Penem APIs and Intermediates Sales Market Share by Type (2019-2024)
Table 53. Global Penem APIs and Intermediates Sales Market Share by Type (2025-2030)
Table 54. Global Penem APIs and Intermediates Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Penem APIs and Intermediates Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Penem APIs and Intermediates Revenue Market Share by Type (2019-2024)
Table 57. Global Penem APIs and Intermediates Revenue Market Share by Type (2025-2030)
Table 58. Global Penem APIs and Intermediates Price (US$/Kg) by Type (2019-2024)
Table 59. Global Penem APIs and Intermediates Price (US$/Kg) by Type (2025-2030)
Table 60. Global Penem APIs and Intermediates Sales (Tons) by Application (2019-2024)
Table 61. Global Penem APIs and Intermediates Sales (Tons) by Application (2025-2030)
Table 62. Global Penem APIs and Intermediates Sales Market Share by Application (2019-2024)
Table 63. Global Penem APIs and Intermediates Sales Market Share by Application (2025-2030)
Table 64. Global Penem APIs and Intermediates Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Penem APIs and Intermediates Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Penem APIs and Intermediates Revenue Market Share by Application (2019-2024)
Table 67. Global Penem APIs and Intermediates Revenue Market Share by Application (2025-2030)
Table 68. Global Penem APIs and Intermediates Price (US$/Kg) by Application (2019-2024)
Table 69. Global Penem APIs and Intermediates Price (US$/Kg) by Application (2025-2030)
Table 70. Shenzhen Haibin Pharmaceutical Company Information
Table 71. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 72. Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Shenzhen Haibin Pharmaceutical Penem APIs and Intermediates Product
Table 74. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 75. Hainan Haiyao Company Information
Table 76. Hainan Haiyao Description and Business Overview
Table 77. Hainan Haiyao Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Hainan Haiyao Penem APIs and Intermediates Product
Table 79. Hainan Haiyao Recent Developments/Updates
Table 80. Qilu Antibiotics Pharmaceutical Company Information
Table 81. Qilu Antibiotics Pharmaceutical Description and Business Overview
Table 82. Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Qilu Antibiotics Pharmaceutical Penem APIs and Intermediates Product
Table 84. Qilu Antibiotics Pharmaceutical Recent Developments/Updates
Table 85. Zhejiang Hisun Pharmaceutical Company Information
Table 86. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 87. Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Zhejiang Hisun Pharmaceutical Penem APIs and Intermediates Product
Table 89. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 90. Zhejiang Hisoar Pharmaceutical Company Information
Table 91. Zhejiang Hisoar Pharmaceutical Description and Business Overview
Table 92. Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Zhejiang Hisoar Pharmaceutical Penem APIs and Intermediates Product
Table 94. Zhejiang Hisoar Pharmaceutical Recent Developments/Updates
Table 95. Sun Pharmaceutical Company Information
Table 96. Sun Pharmaceutical Description and Business Overview
Table 97. Sun Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Penem APIs and Intermediates Product
Table 99. Sun Pharmaceutical Recent Developments/Updates
Table 100. Savior Lifetec Company Information
Table 101. Savior Lifetec Description and Business Overview
Table 102. Savior Lifetec Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Savior Lifetec Penem APIs and Intermediates Product
Table 104. Savior Lifetec Recent Developments/Updates
Table 105. ACS Dobfar Company Information
Table 106. ACS Dobfar Description and Business Overview
Table 107. ACS Dobfar Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. ACS Dobfar Penem APIs and Intermediates Product
Table 109. ACS Dobfar Recent Developments/Updates
Table 110. Kopran Company Information
Table 111. Kopran Description and Business Overview
Table 112. Kopran Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Kopran Penem APIs and Intermediates Product
Table 114. Kopran Recent Developments/Updates
Table 115. High Tech Pharm Company Information
Table 116. High Tech Pharm Description and Business Overview
Table 117. High Tech Pharm Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. High Tech Pharm Penem APIs and Intermediates Product
Table 119. High Tech Pharm Recent Developments/Updates
Table 120. Zhuhai United Laboratories Company Information
Table 121. Zhuhai United Laboratories Description and Business Overview
Table 122. Zhuhai United Laboratories Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Zhuhai United Laboratories Penem APIs and Intermediates Product
Table 124. Zhuhai United Laboratories Recent Developments/Updates
Table 125. Cspc Holdings Company Information
Table 126. Cspc Holdings Description and Business Overview
Table 127. Cspc Holdings Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Cspc Holdings Penem APIs and Intermediates Product
Table 129. Cspc Holdings Recent Developments/Updates
Table 130. Zhejiang Jiuzhou Pharmaceutical Company Information
Table 131. Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
Table 132. Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Zhejiang Jiuzhou Pharmaceutical Penem APIs and Intermediates Product
Table 134. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 135. Jiangxi Fushine Pharmaceutical Company Information
Table 136. Jiangxi Fushine Pharmaceutical Description and Business Overview
Table 137. Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Jiangxi Fushine Pharmaceutical Penem APIs and Intermediates Product
Table 139. Jiangxi Fushine Pharmaceutical Recent Developments/Updates
Table 140. Sichuan Xindi Pharmaceutical Company Information
Table 141. Sichuan Xindi Pharmaceutical Description and Business Overview
Table 142. Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. Sichuan Xindi Pharmaceutical Penem APIs and Intermediates Product
Table 144. Sichuan Xindi Pharmaceutical Recent Developments/Updates
Table 145. Jeil Pharma Company Information
Table 146. Jeil Pharma Description and Business Overview
Table 147. Jeil Pharma Penem APIs and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 148. Jeil Pharma Penem APIs and Intermediates Product
Table 149. Jeil Pharma Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Penem APIs and Intermediates Distributors List
Table 153. Penem APIs and Intermediates Customers List
Table 154. Penem APIs and Intermediates Market Trends
Table 155. Penem APIs and Intermediates Market Drivers
Table 156. Penem APIs and Intermediates Market Challenges
Table 157. Penem APIs and Intermediates Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Penem APIs and Intermediates
Figure 2. Global Penem APIs and Intermediates Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Penem APIs and Intermediates Market Share by Type: 2023 & 2030
Figure 4. APIs Product Picture
Figure 5. Intermediates Product Picture
Figure 6. Global Penem APIs and Intermediates Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Penem APIs and Intermediates Market Share by Application: 2023 & 2030
Figure 8. Meropenem
Figure 9. Imipenem
Figure 10. Biapenem
Figure 11. Ertapenem
Figure 12. Others
Figure 13. Global Penem APIs and Intermediates Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Penem APIs and Intermediates Market Size (2019-2030) & (US$ Million)
Figure 15. Global Penem APIs and Intermediates Sales (2019-2030) & (Tons)
Figure 16. Global Penem APIs and Intermediates Average Price (US$/Kg) & (2019-2030)
Figure 17. Penem APIs and Intermediates Report Years Considered
Figure 18. Penem APIs and Intermediates Sales Share by Manufacturers in 2023
Figure 19. Global Penem APIs and Intermediates Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Penem APIs and Intermediates Players: Market Share by Revenue in Penem APIs and Intermediates in 2023
Figure 21. Penem APIs and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Penem APIs and Intermediates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Penem APIs and Intermediates Sales Market Share by Country (2019-2030)
Figure 24. North America Penem APIs and Intermediates Revenue Market Share by Country (2019-2030)
Figure 25. United States Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Penem APIs and Intermediates Sales Market Share by Country (2019-2030)
Figure 28. Europe Penem APIs and Intermediates Revenue Market Share by Country (2019-2030)
Figure 29. Germany Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Penem APIs and Intermediates Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Penem APIs and Intermediates Revenue Market Share by Region (2019-2030)
Figure 36. China Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Penem APIs and Intermediates Sales Market Share by Country (2019-2030)
Figure 44. Mexico Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Penem APIs and Intermediates Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Penem APIs and Intermediates Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Penem APIs and Intermediates Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Penem APIs and Intermediates by Type (2019-2030)
Figure 54. Global Revenue Market Share of Penem APIs and Intermediates by Type (2019-2030)
Figure 55. Global Penem APIs and Intermediates Price (US$/Kg) by Type (2019-2030)
Figure 56. Global Sales Market Share of Penem APIs and Intermediates by Application (2019-2030)
Figure 57. Global Revenue Market Share of Penem APIs and Intermediates by Application (2019-2030)
Figure 58. Global Penem APIs and Intermediates Price (US$/Kg) by Application (2019-2030)
Figure 59. Penem APIs and Intermediates Value Chain
Figure 60. Penem APIs and Intermediates Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
